339
Last Update Posted: 2017-01-11
Recruiting status is unknown
All Genders accepted | 21 Years-50 Years |
13 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Infusion Laboratory: Protocol 3 (Risperidone) - 4
The purpose of this study is to evaluate clinical safety issues pertaining to risperidone, to cocaine and to its interaction, and to determine how pretreatment with risperidone modifies the subjective as well as physiological effects of cocaine.
Eligibility
Relevant conditions:
Cocaine-Related Disorders
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov